Lower level of miR-34a leads to placenta accreta spectrum by promoting the proliferation, migration of trophoblast villous epithelial cells and enhanced the angiogenesis of vascular endothelial cells

This publication has 43 references indexed in Scilit:

• Evaluation of maternal serum VEGF, TNF-alpha, IL-4, and IL-10 levels in differentiating placenta accreta spectrum from isolated placenta previa
  Cytokine, 2024
• The anti-tumor effects of CT-26 derived exosomes enriched by MicroRNA-34a on murine model of colorectal cancer
  Life Sciences, 2022
• A comparison of recent guidelines in the diagnosis and management of placenta accreta spectrum disorders
  Best Practice & Research Clinical Obstetrics & Gynaecology, 2021
• First trimester serum PAPP-A is associated with placenta accreta: a retrospective study
  Archives of Gynecology and Obstetrics, 2021
• MiR‐182‐5p enhances in vitro neutrophil infiltration in Kawasaki disease
  Molecular Genetics & Genomic Medicine, 2019
• Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis
  American Journal of Obstetrics and Gynecology, 2019
• FIGO consensus guidelines on placenta accreta spectrum disorders: Introduction,
  International Journal of Gynecology & Obstetrics, 2018
• The depletion of MARVELD1 leads to murine placenta accreta via integrin β4‐dependent trophoblast cell invasion
  Journal of Cellular Physiology, 2017
• Cryopreserved embryo transfer is an independent risk factor for placenta accreta
  Fertility and Sterility, 2015
• Re: Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. F. D'Antonio, C. Iacovella and A. Bhide. Ultrasound Obstet Gynecol 2013; 42: 509-517
  Ultrasound in Obstetrics & Gynecology, 2013